Rationale for clinical study of preoperative treatment of soft tissue sarcomas with local ultrasound hyperthermia and chemotherapy with cisplatin and/ or doxorubicin

Cover Page

Cite item

Full Text

Abstract

The aim of the study was to obtain experimental data on the specific antitumor activity of the thermochemotherapy (TCT), which combines local ultrasound hyperthermia and chemotherapy with cisplatin and doxorubicin. Material and methods. The experiments were performed on mice with murine intramuscular transplanted hematogenic metastatic tumors Lewis lung carcinoma LLC and melanoma B16 with average volume of 0,6-1,1 cm3. Local ultrasound hyperthermia (US-HT) was performed on the original ultrasonic device USDT-m with ultrasound of two frequencies (0,88 and 2,64 MHz) simultaneously with a maximum intensity of 2,5-3,0 W/cm2 in the temperature range 41,5-43 °C. Ultrasonic treatment was carried out after systemic chemotherapy with cisplatin (CP) and doxorubicin (Dox). Results. It was shown that local ultrasound hyperthermia and chemotherapy with cisplatin and doxorubicin allows to reduce the size of the tumor in 3-3,5 times, depending on tumor size and dose of cytostatics, with a satisfactory tolerability of treatment. Conclusion. The obtained results suggest a clinical trial of the TCT method with usage of USDT-m promising for preoperative treatment of patients with soft tissue sarcoma in order to achieve operability through cytoreduction of tumor mass.

About the authors

Российский онкологический научный центр им. Н.Н. Блохина РАМН

Author for correspondence.
Russian Federation

Российский онкологический научный центр им. Н.Н. Блохина РАМН

Russian Federation

Московский государственный университет им. Н.В. Ломоносова

Russian Federation

Российский онкологический научный центр им. Н.Н. Блохина РАМН

Email: treshalina@yandex.ru
Russian Federation

Российский онкологический научный центр им. Н.Н. Блохина РАМН

Russian Federation

Российский онкологический научный центр им. Н.Н. Блохина РАМН

Russian Federation

Московский государственный университет им. Н.В. Ломоносова

Russian Federation

Московский государственный университет им. Н.В. Ломоносова

Russian Federation

ФГУП Государственный научный центр «НИОПИК»

Russian Federation

ФГУП Государственный научный центр «НИОПИК»

Russian Federation

N. V. Andronova

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Science

Russian Federation

B. Yu. Bokhyan

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Science

Russian Federation

A. L. Nikolaev

Moscow State University

Russian Federation

E. M. Treshalina

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Science

Russian Federation

M. D. Aliev

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Science

Russian Federation

D. V. Filonenko

N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Science

Russian Federation

A. V. Gopin

Moscow State University

Russian Federation

V. E. Bozhevolnov

Moscow State University

Russian Federation

B. Ya. Kogan

State Research Center NIOPIK

Russian Federation

G. N. Vorozhtcov

State Research Center NIOPIK

Russian Federation

References

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2011 ., ., ., ., ., ., ., ., ., ., Andronova N.V., Bokhyan B.Y., Nikolaev A.L., Treshalina E.M., Aliev M.D., Filonenko D.V., Gopin A.V., Bozhevolnov V.E., Kogan B.Y., Vorozhtcov G.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-66671 от  09.11.2009.